My watch list
my.bionity.com  
Login  

Non-small cell lung carcinoma staging



Non-small cell lung carcinoma staging is an important part of the assessment of patients with non-small cell lung carcinoma (a type of lung cancer). These patients undergo staging as part of the process of considering prognosis and treatment. The American Joint Committee on Cancer (AJCC) recommends TNM staging followed by further grouping.

Contents

TNM staging

The first part of the staging classification is the TNM system.

Primary tumour (T)

  • TX: The primary tumour cannot be assessed, or there are malignant cells in the sputum or bronchoalveolar lavage but not seen on imaging or bronchoscopy.
  • Tis: Carcinoma in situ.
  • T0: No evidence of primary tumour.
  • T1: Tumour less than 3 cm in its greatest dimension, surrounded by lung or visceral pleura and without bronchoscopic invasion into the main bronchus.
  • T2: A tumour with any of: -
    • More than 3 cm in greatest dimension.
    • Extending into the main bronchus, but more than 2 cm distal to the carina.
    • Obstructive pneumonitis, but not involving the entire lung.
  • T3: A tumour with any of: -
    • Invasion of the chest wall, diaphragm, mediastinal pleura, or parietal pericardium.
    • Extending into the main bronchus, within 2 cm of the carina, but not involving the carina.
    • Obstructive pneumonitis of the entire lung.
  • T4: A tumour with any of: -

Lymph nodes (N)

  • NX: Lymph nodes cannot be assessed.
  • N0: No lymph nodes involved.
  • N1: Metastasis to ipsilateral peribronchial or ipsilateral hilar lymph nodes.
  • N2: Metastasis to ipsilateral mediastinal or subcarinal lymph nodes.
  • N3: Metastasis to any of: -
    • Ipsilateral supraclavicular lymph nodes.
    • Ipsilateral scalene lymph nodes.
    • Contralateral lymph nodes.

Distant metastasis (M)

  • MX: Distant metastasis cannot be assessed.
  • M0: No distant metastasis.
  • M1: Distant metastasis is present.

Mountain classification

Clifton Mountain, a surgeon in Texas, assigned further categories of staging on the basis of similarities in treatment and prognosis.[1]

Non-small cell lung carcinoma staging
Grouping TNM staging
Occult carcinoma TX N0 M0
Stage 0 Tis N0 M0
Stage IA T1 N0 M0
Stage IB T2 N0 M0
Stage IIA T1 N1 M0
Stage IIB T2 N1 M0
T3 N0 M0
Stage IIIA T1 N2 M0
T2 N2 M0
T3 N1 M0
T3 N2 M0
Stage IIIB Any T N3 M0
T4 Any N M0
Stage IV Any T Any N M1

Prognosis

Non-small cell lung carcinoma survival by stage[2]
Grouping Survival rate (per cent)
One year Two years Three years Four years Five years
IA 91% 79% 71% 67% 61%
IB 72% 54% 46% 41% 38%
IIA 79% 49% 38% 34% 34%
IIB 59% 41% 33% 26% 24%
IIIA 50% 25% 18% 14% 13%
IIIB 34% 13% 7% 6% 5%
IV 19% 6% 2% 2% 1%

References

  1. ^ Mountain, Clifton F; Herman I Libshitz, Kay E Hermes. A Handbook for Staging, Imaging, and Lymph Node Classification. Charles P Young Company. 
  2. ^ Mountain, CF (1997). "Revisions in the international system for staging lung cancer". Chest 111: 1710-1717. American College of Chest Physicians.
 
This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Non-small_cell_lung_carcinoma_staging". A list of authors is available in Wikipedia.
Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE